{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T04:58:26Z","timestamp":1791781106058,"version":"4.3.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["grant 23667"],"award-info":[{"award-number":["grant 23667"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Amyotrophic lateral sclerosis (ALS) is characterised by degeneration of motor neurons, leading to muscle weakness and progressive paralysis. Currently, no treatment is available to halt or reverse the progression of the disease. Oxidative stress, mitochondrial dysfunction, accumulation of unfolded proteins and inflammation are interconnected key actors involved in ALS. A potent therapeutic strategy would be to find molecules that break this vicious circle leading to neuronal dysfunction and death. Targeting sigma-1 receptor (S1R) could meet this objective, as this chaperone protein modulates many cell survival mechanisms. So far, the impact of S1R activation in ALS has been studied using specific agonists and mostly on the\n                      <jats:italic>SOD1<\/jats:italic>\n                      mutation that represents only 2% of patients. In the present study, the impact of two different S1R activators, the reference agonist PRE-084 and the positive modulator OZP002, was compared on two key ALS genes:\n                      <jats:italic>TDP43<\/jats:italic>\n                      and\n                      <jats:italic>C9orf72<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The dissociation of S1R from Binding immunoglobulin Protein (BiP) was determined using ELISA. OZP002 toxicity was compared to PRE-084 on zebrafish larvae with increasing concentrations. The efficacy of OZP002 and PRE-084 was evaluated on the locomotor escape response of zebrafish expressing mutant TDP43 or one C9orf72 toxic dipeptide. Their effects on NRF2 target gene expression were studied by qPCR. The beneficial effect was further examined on the locomotor performances of TDP43\n                      <jats:sup>A315T<\/jats:sup>\n                      mice using rotarod and beam walking tests. We also performed analysis on motor neuron loss and glial reactivity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      OZP002 is a positive modulator of S1R, that increases the dissociation of the S1R-BiP complex induced by orthosteric agonists. S1R activation by both OZP002 and PRE-084 restored the locomotor response of ALS zebrafish expressing either TDP43 or one C9orf72 toxic dipeptide. The neuroprotection was due at least in part to the NRF2 cascade stimulation but not with a direct interaction. More importantly, OZP002 and PRE-084 prevented locomotor defects and degeneration of spinal motor neurons in TDP43\n                      <jats:sup>A315T<\/jats:sup>\n                      transgenic mice. Astroglial and microglial reactivities were also reduced by both activators.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We here emphasize the therapeutic value of S1R activation in mitigating ALS pathology. Additionally, we show that the positive modulators pave the way for the development of new S1R-activating compounds for ALS treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40035-025-00527-z","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T02:35:41Z","timestamp":1765766141000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Positive modulation of sigma-1 receptor: a new weapon to mitigate disease progression in amyotrophic lateral sclerosis"],"prefix":"10.1186","volume":"14","author":[{"given":"Julien","family":"Le Friec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Mourier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Couly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Cubedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Meunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Delprat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"De Zordo-Banliat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahar","family":"Ayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Virieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Ping","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Lasbleiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tangui","family":"Maurice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0139-2291","authenticated-orcid":false,"given":"Jean-Charles","family":"Li\u00e9vens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"issue":"10","key":"527_CR1","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/ene.14393","volume":"27","author":"P Masrori","year":"2020","unstructured":"Masrori P, Van Damme P. Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol. 2020;27(10):1918\u201329.","journal-title":"Eur J Neurol"},{"issue":"5","key":"527_CR2","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/WCO.0000000000001294","volume":"37","author":"M Nijs","year":"2024","unstructured":"Nijs M, Van Damme P. The genetics of amyotrophic lateral sclerosis. Curr Opin Neurol. 2024;37(5):560\u20139.","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"527_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","volume":"72","author":"M DeJesus-Hernandez","year":"2011","unstructured":"DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72(2):245\u201356.","journal-title":"Neuron"},{"issue":"2","key":"527_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","volume":"72","author":"AE Renton","year":"2011","unstructured":"Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257\u201368.","journal-title":"Neuron"},{"issue":"3","key":"527_CR5","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","volume":"351","author":"T Arai","year":"2006","unstructured":"Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351(3):602\u201311.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"527_CR6","volume":"2012","author":"RG Miller","year":"2012","unstructured":"Miller RG, Mitchell JD, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND). Cochrane Database Syst Rev. 2012;2012(3):CD001447.","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"527_CR7","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1172\/JCI99081","volume":"128","author":"A McCampbell","year":"2018","unstructured":"McCampbell A, Cole T, Wegener AJ, Tomassy GS, Setnicka A, Farley BJ, et al. Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models. J Clin Invest. 2018;128(8):3558\u201367.","journal-title":"J Clin Invest"},{"issue":"2","key":"527_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa2003715","volume":"383","author":"T Miller","year":"2020","unstructured":"Miller T, Cudkowicz M, Shaw PJ, Andersen PM, Atassi N, Bucelli RC, et al. Phase 1\u20132 trial of antisense oligonucleotide tofersen for SOD1 ALS. N Engl J Med. 2020;383(2):109\u201319.","journal-title":"N Engl J Med"},{"issue":"6","key":"527_CR9","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/ana.22534","volume":"70","author":"A Al-Saif","year":"2011","unstructured":"Al-Saif A, Al-Mohanna F, Bohlega S. A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. Ann Neurol. 2011;70(6):913\u20139.","journal-title":"Ann Neurol"},{"key":"527_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/164_2017_15","volume":"244","author":"T Maurice","year":"2017","unstructured":"Maurice T, Goguadze N. Sigma-1 (sigma(1)) receptor in memory and neurodegenerative diseases. Handb Exp Pharmacol. 2017;244:81\u2013108.","journal-title":"Handb Exp Pharmacol"},{"key":"527_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/978-3-319-50174-1_10","volume":"964","author":"L Nguyen","year":"2017","unstructured":"Nguyen L, Lucke-Wold BP, Mookerjee S, Kaushal N, Matsumoto RR. Sigma-1 receptors and neurodegenerative diseases: towards a hypothesis of Sigma-1 receptors as amplifiers of neurodegeneration and neuroprotection. Adv Exp Med Biol. 2017;964:133\u201352.","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"527_CR12","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.tips.2016.01.003","volume":"37","author":"TP Su","year":"2016","unstructured":"Su TP, Su TC, Nakamura Y, Tsai SY. The sigma-1 receptor as a pluripotent modulator in living systems. Trends Pharmacol Sci. 2016;37(4):262\u201378.","journal-title":"Trends Pharmacol Sci"},{"issue":"5","key":"527_CR13","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1111\/ejn.15608","volume":"55","author":"HM Estevez-Silva","year":"2022","unstructured":"Estevez-Silva HM, Mediavilla T, Giacobbo BL, Liu X, Sultan FR, Marcellino DJ. Pridopidine modifies disease phenotype in a SOD1 mouse model of amyotrophic lateral sclerosis. Eur J Neurosci. 2022;55(5):1356\u201372.","journal-title":"Eur J Neurosci"},{"key":"527_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.780588","volume":"12","author":"N Gaja-Capdevila","year":"2021","unstructured":"Gaja-Capdevila N, Hernandez N, Navarro X, Herrando-Grabulosa M. Sigma-1 receptor is a pharmacological target to promote neuroprotection in the SOD1(G93A) ALS mice. Front Pharmacol. 2021;12:780588.","journal-title":"Front Pharmacol"},{"issue":"3","key":"527_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41419-019-1451-2","volume":"10","author":"A Ionescu","year":"2019","unstructured":"Ionescu A, Gradus T, Altman T, Maimon R, Saraf Avraham N, Geva M, et al. Targeting the sigma-1 receptor via pridopidine ameliorates central features of ALS pathology in a SOD1(G93A) model. Cell Death Dis. 2019;10(3):210.","journal-title":"Cell Death Dis"},{"issue":"4","key":"527_CR16","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s13311-012-0140-y","volume":"9","author":"R Mancuso","year":"2012","unstructured":"Mancuso R, Olivan S, Rando A, Casas C, Osta R, Navarro X. Sigma-1R agonist improves motor function and motoneuron survival in ALS mice. Neurotherapeutics. 2012;9(4):814\u201326.","journal-title":"Neurotherapeutics"},{"key":"527_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.neulet.2013.12.005","volume":"559","author":"Y Ono","year":"2014","unstructured":"Ono Y, Tanaka H, Takata M, Nagahara Y, Noda Y, Tsuruma K, et al. SA4503, a sigma-1 receptor agonist, suppresses motor neuron damage in in vitro and in vivo amyotrophic lateral sclerosis models. Neurosci Lett. 2014;559:174\u20138.","journal-title":"Neurosci Lett"},{"key":"527_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102542","volume":"58","author":"C Lasbleiz","year":"2022","unstructured":"Lasbleiz C, Peyrel A, Tarot P, Sarniguet J, Crouzier L, Cubedo N, et al. Sigma-1 receptor agonist PRE-084 confers protection against TAR DNA-binding protein-43 toxicity through NRF2 signalling. Redox Biol. 2022;58:102542.","journal-title":"Redox Biol"},{"key":"527_CR19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3389\/fphar.2019.00223","volume":"10","author":"E Vavers","year":"2019","unstructured":"Vavers E, Zvejniece L, Maurice T, Dambrova M. Allosteric modulators of sigma-1 receptor: a review. Front Pharmacol. 2019;10:223.","journal-title":"Front Pharmacol"},{"issue":"6","key":"527_CR20","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1039\/b919345f","volume":"8","author":"JN Volle","year":"2010","unstructured":"Volle JN, Filippini D, Krawczy B, Kaloyanov N, Van der Lee A, Maurice T, et al. Drug discovery: phosphinolactone, in vivo bioisostere of the lactol group. Org Biomol Chem. 2010;8(6):1438\u201344.","journal-title":"Org Biomol Chem"},{"issue":"3","key":"527_CR21","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","volume":"131","author":"T Hayashi","year":"2007","unstructured":"Hayashi T, Su TP. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell. 2007;131(3):596\u2013610.","journal-title":"Cell"},{"issue":"2","key":"527_CR22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4103\/0976-500X.72351","volume":"1","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. J Pharmacol Pharmacother. 2010;1(2):94\u20139.","journal-title":"J Pharmacol Pharmacother"},{"issue":"6","key":"527_CR23","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1074\/jbc.M708702200","volume":"283","author":"L Li","year":"2008","unstructured":"Li L, Kobayashi M, Kaneko H, Nakajima-Takagi Y, Nakayama Y, Yamamoto M. Molecular evolution of Keap1. Two Keap1 molecules with distinctive intervening region structures are conserved among fish. J Biol Chem. 2008;283(6):3248\u201355.","journal-title":"J Biol Chem"},{"issue":"11","key":"527_CR24","doi-asserted-by":"publisher","first-page":"dmm049092","DOI":"10.1242\/dmm.049092","volume":"14","author":"FW Riemslagh","year":"2021","unstructured":"Riemslagh FW, Verhagen RFM, van der Toorn EC, Smits DJ, Quint WH, van der Linde HC, et al. Reduction of oxidative stress suppresses poly-GR-mediated toxicity in zebrafish embryos. Dis Model Mech.\u00a02021;14(11):dmm049092.","journal-title":"Dis Model Mech"},{"issue":"7","key":"527_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042117","volume":"7","author":"A Vaccaro","year":"2012","unstructured":"Vaccaro A, Patten SA, Ciura S, Maios C, Therrien M, Drapeau P, et al. Methylene blue protects against TDP-43 and FUS neuronal toxicity in C. elegans and D. rerio. PLoS ONE. 2012;7(7):e42117.","journal-title":"PLoS ONE"},{"issue":"7","key":"527_CR26","doi-asserted-by":"publisher","first-page":"4609","DOI":"10.1074\/jbc.M111.260125","volume":"287","author":"AR Timme-Laragy","year":"2012","unstructured":"Timme-Laragy AR, Karchner SI, Franks DG, Jenny MJ, Harbeitner RC, Goldstone JV, et al. Nrf2b, novel zebrafish paralog of oxidant-responsive transcription factor NF-E2-related factor 2 (NRF2). J Biol Chem. 2012;287(7):4609\u201327.","journal-title":"J Biol Chem"},{"issue":"4","key":"527_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"1","key":"527_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00018-023-05023-z","volume":"81","author":"S Couly","year":"2024","unstructured":"Couly S, Yasui Y, Foncham S, Grammatikakis I, Lal A, Shi L, et al. Benzomorphan and non-benzomorphan agonists differentially alter sigma-1 receptor quaternary structure, as does types of cellular stress. Cell Mol Life Sci. 2024;81(1):14.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"527_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/iep.12006","volume":"94","author":"MA Esmaeili","year":"2013","unstructured":"Esmaeili MA, Panahi M, Yadav S, Hennings L, Kiaei M. Premature death of TDP-43 (A315T) transgenic mice due to gastrointestinal complications prior to development of full neurological symptoms of amyotrophic lateral sclerosis. Int J Exp Pathol. 2013;94(1):56\u201364.","journal-title":"Int J Exp Pathol"},{"key":"527_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.brainres.2013.10.013","volume":"1584","author":"T Hatzipetros","year":"2014","unstructured":"Hatzipetros T, Bogdanik LP, Tassinari VR, Kidd JD, Moreno AJ, Davis C, et al. C57BL\/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS. Brain Res. 2014;1584:59\u201372.","journal-title":"Brain Res"},{"issue":"631","key":"527_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abh3763","volume":"14","author":"L Crouzier","year":"2022","unstructured":"Crouzier L, Danese A, Yasui Y, Richard EM, Lievens JC, Patergnani S, et al. Activation of the sigma-1 receptor chaperone alleviates symptoms of Wolfram syndrome in preclinical models. Sci Transl Med. 2022;14(631):eabh3763.","journal-title":"Sci Transl Med"},{"key":"527_CR32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.phrs.2019.04.026","volume":"144","author":"T Maurice","year":"2019","unstructured":"Maurice T, Volle JN, Strehaiano M, Crouzier L, Pereira C, Kaloyanov N, et al. Neuroprotection in non-transgenic and transgenic mouse models of Alzheimer\u2019s disease by positive modulation of sigma(1) receptors. Pharmacol Res. 2019;144:315\u201330.","journal-title":"Pharmacol Res"},{"issue":"3","key":"527_CR33","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/cne.10988","volume":"468","author":"M Landry","year":"2004","unstructured":"Landry M, Bouali-Benazzouz R, El Mestikawy S, Ravassard P, Nagy F. Expression of vesicular glutamate transporters in rat lumbar spinal cord, with a note on dorsal root ganglia. J Comp Neurol. 2004;468(3):380\u201394.","journal-title":"J Comp Neurol"},{"issue":"1","key":"527_CR34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3121","volume":"13","author":"EB Lee","year":"2011","unstructured":"Lee EB, Lee VM, Trojanowski JQ. Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat Rev Neurosci. 2011;13(1):38\u201350.","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"527_CR35","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.neuron.2013.02.004","volume":"77","author":"PE Ash","year":"2013","unstructured":"Ash PE, Bieniek KF, Gendron TF, Caulfield T, Lin WL, Dejesus-Hernandez M, et al. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD\/ALS. Neuron. 2013;77(4):639\u201346.","journal-title":"Neuron"},{"issue":"1","key":"527_CR36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/syn.20984","volume":"66","author":"SY Tsai","year":"2012","unstructured":"Tsai SY, Rothman RK, Su TP. Insights into the Sigma-1 receptor chaperone\u2019s cellular functions: a microarray report. Synapse. 2012;66(1):42\u201351.","journal-title":"Synapse"},{"issue":"44","key":"527_CR37","doi-asserted-by":"publisher","first-page":"18809","DOI":"10.1073\/pnas.0908767106","volume":"106","author":"I Wegorzewska","year":"2009","unstructured":"Wegorzewska I, Bell S, Cairns NJ, Miller TM, Baloh RH. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A. 2009;106(44):18809\u201314.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"527_CR38","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1002\/cne.23848","volume":"523","author":"SK Vaughan","year":"2015","unstructured":"Vaughan SK, Kemp Z, Hatzipetros T, Vieira F, Valdez G. Degeneration of proprioceptive sensory nerve endings in mice harboring amyotrophic lateral sclerosis-causing mutations. J Comp Neurol. 2015;523(17):2477\u201394.","journal-title":"J Comp Neurol"},{"issue":"1","key":"527_CR39","doi-asserted-by":"publisher","first-page":"14266","DOI":"10.1038\/s41598-017-14399-5","volume":"7","author":"L Bargsted","year":"2017","unstructured":"Bargsted L, Medinas DB, Martinez Traub F, Rozas P, Munoz N, Nassif M, et al. Disulfide cross-linked multimers of TDP-43 and spinal motoneuron loss in a TDP-43(A315T) ALS\/FTD mouse model. Sci Rep. 2017;7(1):14266.","journal-title":"Sci Rep"},{"issue":"2","key":"527_CR40","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/mus.28169","volume":"70","author":"DV Neel","year":"2024","unstructured":"Neel DV, Baselga-Garriga C, Benson M, Keegan M, Chase M, D\u2019Agostino D, et al. Multicenter expanded access program for access to investigational products for amyotrophic lateral sclerosis. Muscle Nerve. 2024;70(2):232\u20139.","journal-title":"Muscle Nerve"},{"issue":"5796","key":"527_CR41","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130\u20133.","journal-title":"Science"},{"issue":"8","key":"527_CR42","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.tips.2007.06.008","volume":"28","author":"TW Schwartz","year":"2007","unstructured":"Schwartz TW, Holst B. Allosteric enhancers, allosteric agonists and ago-allosteric modulators: where do they bind and how do they act? Trends Pharmacol Sci. 2007;28(8):366\u201373.","journal-title":"Trends Pharmacol Sci"},{"issue":"22","key":"527_CR43","doi-asserted-by":"publisher","first-page":"5474","DOI":"10.3390\/molecules25225474","volume":"25","author":"S Saha","year":"2020","unstructured":"Saha S, Buttari B, Panieri E, Profumo E, Saso L. An overview of Nrf2 signaling pathway and its role in inflammation. Molecules. 2020;25(22):5474.","journal-title":"Molecules"},{"issue":"11","key":"527_CR44","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1002\/ijc.22978","volume":"121","author":"PE Gibbs","year":"2007","unstructured":"Gibbs PE, Maines MD. Biliverdin inhibits activation of NF-kappaB: reversal of inhibition by human biliverdin reductase. Int J Cancer. 2007;121(11):2567\u201374.","journal-title":"Int J Cancer"},{"issue":"46","key":"527_CR45","doi-asserted-by":"publisher","first-page":"18849","DOI":"10.1073\/pnas.1108571108","volume":"108","author":"B Wegiel","year":"2011","unstructured":"Wegiel B, Gallo D, Csizmadia E, Roger T, Kaczmarek E, Harris C, et al. Biliverdin inhibits Toll-like receptor-4 (TLR4) expression through nitric oxide-dependent nuclear translocation of biliverdin reductase. Proc Natl Acad Sci U S A. 2011;108(46):18849\u201354.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"527_CR46","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/nm0302-240","volume":"8","author":"TS Lee","year":"2002","unstructured":"Lee TS, Chau LY. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med. 2002;8(3):240\u20136.","journal-title":"Nat Med"},{"issue":"4","key":"527_CR47","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/74680","volume":"6","author":"LE Otterbein","year":"2000","unstructured":"Otterbein LE, Bach FH, Alam J, Soares M, Tao LuH, Wysk M, et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med. 2000;6(4):422\u20138.","journal-title":"Nat Med"},{"issue":"5","key":"527_CR48","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.4103\/1673-5374.385283","volume":"19","author":"P Tarot","year":"2024","unstructured":"Tarot P, Lasbleiz C, Li\u00e9vens JC. NRF2 signaling cascade in amyotrophic lateral sclerosis: bridging the gap between promise and reality. Neural Regen Res. 2024;19(5):1006\u201312.","journal-title":"Neural Regen Res"},{"issue":"22","key":"527_CR49","doi-asserted-by":"publisher","first-page":"8137","DOI":"10.1128\/MCB.23.22.8137-8151.2003","volume":"23","author":"DD Zhang","year":"2003","unstructured":"Zhang DD, Hannink M. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol. 2003;23(22):8137\u201351.","journal-title":"Mol Cell Biol"},{"issue":"6","key":"527_CR50","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3390\/antiox10060981","volume":"10","author":"SR Barwick","year":"2021","unstructured":"Barwick SR, Siddiq MS, Wang J, Xiao H, Marshall B, Perry E, et al. Sigma 1 receptor co-localizes with NRF2 in retinal photoreceptor cells. Antioxidants.\u00a02021;10(6):981.","journal-title":"Antioxidants"},{"issue":"4","key":"527_CR51","doi-asserted-by":"publisher","first-page":"955","DOI":"10.7150\/ijms.104324","volume":"22","author":"C Yuan","year":"2025","unstructured":"Yuan C, Chang F, Zhou Q, Chen F, Gao X, Yusufu A, et al. S1R mediates NRF2 dependent ferroptosis of renal tubular epithelial cells to promote renal fibrosis in diabetic nephropathy. Int J Med Sci. 2025;22(4):955\u201370.","journal-title":"Int J Med Sci"},{"key":"527_CR52","doi-asserted-by":"publisher","first-page":"4582135","DOI":"10.1155\/2017\/4582135","volume":"2017","author":"TY Weng","year":"2017","unstructured":"Weng TY, Hung DT, Su TP, Tsai SA. Loss of Sigma-1 receptor chaperone promotes astrocytosis and enhances the Nrf2 antioxidant defense. Oxid Med Cell Longev. 2017;2017:4582135.","journal-title":"Oxid Med Cell Longev"},{"key":"527_CR53","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.freeradbiomed.2023.06.010","volume":"205","author":"J Wang","year":"2023","unstructured":"Wang J, Barwick SR, Xiao H, Smith SB. Evaluation of the role of Sigma 1 receptor and Cullin3 in retinal photoreceptor cells. Free Radic Biol Med. 2023;205:214\u201323.","journal-title":"Free Radic Biol Med"},{"key":"527_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111382","volume":"127","author":"Z Li","year":"2024","unstructured":"Li Z, Zhou J, Cui S, Hu S, Li B, Liu X, et al. Activation of sigma-1 receptor ameliorates sepsis-induced myocardial injury by mediating the Nrf2\/HO1 signaling pathway to attenuate mitochondrial oxidative stress. Int Immunopharmacol. 2024;127:111382.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"527_CR55","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.neuroscience.2010.02.022","volume":"167","author":"TA Mavlyutov","year":"2010","unstructured":"Mavlyutov TA, Epstein ML, Andersen KA, Ziskind-Conhaim L, Ruoho AE. The sigma-1 receptor is enriched in postsynaptic sites of C-terminals in mouse motoneurons. An anatomical and behavioral study. Neuroscience. 2010;167(2):247\u201355.","journal-title":"Neuroscience"},{"key":"527_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134387","volume":"711","author":"Y Wang","year":"2019","unstructured":"Wang Y, Zhao CS. Sigma-1 receptor activation ameliorates LPS-induced NO production and ROS formation through the Nrf2\/HO-1 signaling pathway in cultured astrocytes. Neurosci Lett. 2019;711:134387.","journal-title":"Neurosci Lett"},{"issue":"7","key":"527_CR57","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/glia.20802","volume":"57","author":"AA Hall","year":"2009","unstructured":"Hall AA, Herrera Y, Ajmo CT Jr, Cuevas J, Pennypacker KR. Sigma receptors suppress multiple aspects of microglial activation. Glia. 2009;57(7):744\u201354.","journal-title":"Glia"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-025-00527-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-025-00527-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-025-00527-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T15:04:53Z","timestamp":1765811093000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40035-025-00527-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["527"],"URL":"https:\/\/doi.org\/10.1186\/s40035-025-00527-z","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"T. Maurice and D. Virieux are co-inventors of the patent FR1653960, PCT\/EP2017\/060129, 2016, describing OZP002.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All experimental procedures on animals were in accordance with the 2010\/63\/EU Directive and the ARRIVE guidelines. Experiments on mice were authorized by the National Ethic Committee (Paris) (APAFIS #33337-2021093015356901 v6).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"68"}}